|

EPI-326 Clinical Trials

1 actively recruiting trial across 1 location

Also known as: EPI-326 Injection

Pipeline

Phase 1: 1

Top Sponsors

  • EpiBiologics1

Indications

  • Head and Neck1
  • Non Small Cell1
  • Epidermal Growth Factor1
  • Epidermal Growth Factor Receptor1
  • Non-Small-Cell Lung1

Los Angeles, California1 trial

A Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCC

START Los Angeles

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.